<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7A985B29-5945-4035-A62A-0CBF9C037FCA"><gtr:id>7A985B29-5945-4035-A62A-0CBF9C037FCA</gtr:id><gtr:name>Cold Spring Harbor Laboratory (CSHL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/040001EB-7CD7-4B8C-998C-7097FA7B9B98"><gtr:id>040001EB-7CD7-4B8C-998C-7097FA7B9B98</gtr:id><gtr:name>Mount Sinai Hospital (Canada)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Centre for Molecular Medicine</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7A985B29-5945-4035-A62A-0CBF9C037FCA"><gtr:id>7A985B29-5945-4035-A62A-0CBF9C037FCA</gtr:id><gtr:name>Cold Spring Harbor Laboratory (CSHL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/040001EB-7CD7-4B8C-998C-7097FA7B9B98"><gtr:id>040001EB-7CD7-4B8C-998C-7097FA7B9B98</gtr:id><gtr:name>Mount Sinai Hospital (Canada)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/192DA4C6-9B8F-4972-BEC5-7719B58DC952"><gtr:id>192DA4C6-9B8F-4972-BEC5-7719B58DC952</gtr:id><gtr:firstName>Joanne</gtr:firstName><gtr:surname>Millar</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1499F3BD-F827-4C0C-95A7-03B5292D5106"><gtr:id>1499F3BD-F827-4C0C-95A7-03B5292D5106</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Porteous</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B301A87E-C8C2-4F6F-B81E-87518461B477"><gtr:id>B301A87E-C8C2-4F6F-B81E-87518461B477</gtr:id><gtr:firstName>Douglas</gtr:firstName><gtr:surname>Blackwood</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BEF1FF45-EA1C-4E16-BFE4-7844A8F5B77E"><gtr:id>BEF1FF45-EA1C-4E16-BFE4-7844A8F5B77E</gtr:id><gtr:firstName>Walter John</gtr:firstName><gtr:surname>Muir</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600214"><gtr:id>0D445FFF-C31C-4448-A601-6C7906B56BBE</gtr:id><gtr:title>Neurobiology of the DISC1 pathway</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600214</gtr:grantReference><gtr:abstractText>Bipolar affective disorder and schizophrenia are severe forms of mental illness that together affect approximately one in fifty people at some time in their life. We know very little about what goes wrong in the brains of people suffering from mental illness. However, we do know that these illnesses tend to cluster in families, pointing to genetic (inherited) factors being important in increasing risk of becoming mentally ill. We have identified two such genetic factors, genes called DISC1 and PDE4B, that are damaged in some patients diagnosed with mental illness. DISC1 and PDE4B work together to control the amount of a signalling molecule called cAMP, which is needed for many important brain functions, including some of the thought processes that are abnormal in psychiatric patients. Now we want to understand in more detail how DISC1 and PDE4B interact with other factors in brain cells to carry out essential biological tasks. This will tell us more about the effect of damage to these genes upon brain function, and how this leads to mental illness. If we can understand what happens in the brain in mental illness this work may ultimately lead to development of better ways to treat schizophrenia and bipolar affective disorder.</gtr:abstractText><gtr:technicalSummary>Bipolar affective disorder and schizophrenia are both in the WHO top ten estimates for disease related lifetime disability. Jointly, they have a lifetime incidence of about 2%. Both have strong genetic components, but until recently few genetic findings were consistently replicated. In 2000, we positionally cloned a completely novel gene, Disrupted in Schizophrenia 1, so named because it was identified at the breakpoint of a balanced translocation that segregates with schizophrenia, bipolar affective disorder and recurrent major depression in a large Scottish family. The translocation family is possibly unique, but multiple groups, world-wide, have tested DISC1 in patients without any chromosomal rearrangement and found positive evidence for genetic linkage and association with schizophrenia, bipolar affective disorder and schizoaffective disorder. Our understanding of the biological function of DISC1 has grown steadily. We and others have shown that DISC1 is a putative scaffold protein which interacts with multiple protein partners involved in neurodevelopment, cytoskeletal function and cell signalling. Our most recent study resulted in a dramatic change in the understanding of DISC1 function through first, our identification of phosphodiesterase 4B (PDE4B) as a candidate genetic risk factor and second, our demonstration that DISC1 interacts dynamically with PDE4B to modulate cAMP, a key neuronal signalling molecule. DISC1 is arguably now the best replicated genetic finding and the DISC1/PDE4B pathway the most promising biological pathway underpinning schizophrenia and bipolar affective disorder, and a promising target for novel drug development. 

In this proposal we will address four related objectives:
1. How is expression of DISC1 regulated and what are the consequences of aberrant DISC1 expression at the cellular level?
2. What is the role of DISC1 in subcellular targeting of its binding partners? 
3. What is the role of DISC1 in mitochondrial trafficking, neurite extension and synaptic activity?
4. What is the molecular nature of the interaction between DISC1 and PDE4B and how is it regulated?
At the end of this research grant we expect to have made significant inroads into the molecular basis of DISC1 regulation, how this is affected by genetic variation, where in the cell and with which DISC1 isoforms PDE4B and other proteins interact, how these interactions are affected by modulation of DISC1 expression, and the impact this has upon neural cell development and activity. We also expect to have defined and developed an assay for monitoring the molecular interaction between DISC1 and PDE4B as a key step towards a future drug development programme.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1133545</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Molecular Cell and Systems Biology</gtr:department><gtr:description>Houslay/Baillie lab</gtr:description><gtr:id>193A5EE3-96FC-48CB-BACE-C74C37B1E800</gtr:id><gtr:impact>This collaboration has resulted in two collaborative papers: 1) a high impact paper in Science 'DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signalling'. This paper reported the first link between DISC1 and PDE4. 2) A paper further examining the biochemistry underlying this interaction 'Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels'. This collaboration also made the important discovery that the two DISC1 mutations in mice are located within PDE4B binding sites, and thus contributed to another high impact paper in Neuron 'behavioural phenotypes of Disc1 missense mutations in mice' demonstrating for the first time that mutations in DISC1 cause mouse phenotypes related to human mental illness. Another collaborative paper is in preparation. This collaboration is not multidisciplinary.</gtr:impact><gtr:partnerContribution>Our collaborator Miles Houslay has provided access to biochemical reagents, training, peptide array technology (mapping of binding sites on DISC1, PDE4, AKAP9, GluN1, GSK3B) and his extensive knowledge of phosphodiesterases. Miles Houslay has now retired and we collaborate with George Baillie who is now head of the laboratory.</gtr:partnerContribution><gtr:piContribution>We made the link between DISC1 and PDE4 and jointly mapped DISC1/PDE4, DISC1/AKAP9, DISC1/NR1(GluN1), PDE4/NR1(GluN1) and DISC1/GSK3B binding sites. We continue to jointly examine DISc1/PDE4 biology. We have contributed reagents to facilitate Baillie's study of DISc1 turnover.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mount Sinai Hospital (Canada)</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Samuel Lunenfeld Research Institute</gtr:department><gtr:description>Roder/Clapcote</gtr:description><gtr:id>CE98DCF4-B7A5-4191-BAB5-0F6E1D477797</gtr:id><gtr:impact>This collaboration resulted in a high profile collaborative publication in Neuron 'behavioural phenotypes of Disc1 missense mutations in mice'. Two other collaborative studies have also been published: 'Disc1 variation leads to specific alterations in adult neurogenesis' and 'Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia'. This collaboration is multidisciplinary, involving behavioural analysis, protein biochemistry, neuroscience, cell biology, protein biochemistry and transcriptomics.</gtr:impact><gtr:partnerContribution>This collaboration enabled us to access mice carrying missense mutations in DISC1 for biochemical and transcriptomic analysis.</gtr:partnerContribution><gtr:piContribution>We provided biochemical data that may explain, at least in part, the behavioural, pharmacological and anatomical phenotypes of ENU-induced mutant mice. We also obtained data from transcriptome analysis that strengthens the eveidence for genetic links between schizophrenia and autism. We have a general agreement to continue collaborating in the future, most likely over the t(1;11) mouse model from Sanofi.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cold Spring Harbor Laboratory (CSHL)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>CSHL sequencing</gtr:description><gtr:id>0E585AF3-66B1-498E-9785-413D05FD0733</gtr:id><gtr:impact>This collaboration has identitifed a further instance of a severe mutation in DISC1, previously identitifed in one case only. This mutation may thus be more prevalent than previously thought. A manuscript describing the first round of data has now been published: '708 Common and 2010 rare DISC1 locus variants identified in 1542 subjects: analysis for association with psychiatric disorder and cognitive traits'. This collaboration is not multi-disciplinary.</gtr:impact><gtr:partnerContribution>Our collaborators Richard McCombie and James Watson are providing genomic sequence information for DISC1 and a subset of DISC1 binding partners. A matched set of controls and cases diagnosed with major mental illness are being sequenced to identify putative causal mutations. Such mutations will be tested in a range of our biochemical assays.</gtr:partnerContribution><gtr:piContribution>We provided information about promising candidate genes for genomic resequencing in patients with a diagnosis of mental illness.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Edinburgh Science Festival presentation</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EB57E19F-7769-4837-B49D-A1F1EB5A4DB4</gtr:id><gtr:impact>We prepared a stall designed to interest school children in the subject of genetics and to introduce the idea that many of our characteristics are inherited. The children showed a lot of interest in this idea. We also included some information on mental illness and genetics for parents, designed to demonstrate how prevalent mental illness is, illustrated by a list of famous people with a diagnosis of schizophrenia or depression. This part of our stall had a big impact. We contribute every year to the Science Festival and other University/MRC workshops aimed at school children.

The excellent annual attendance at the festival demonstrates its impact.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CWMT Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B7F672A0-3A9D-4E24-8230-19883530D706</gtr:id><gtr:impact>Invited keynote research summary for Charle Whaller Memorial Trust Newsletter

Feedback from readers</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh City Council</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>18B695E3-01CB-4B6B-BD2A-87363D9073B9</gtr:id><gtr:impact>Circa 150 people attending the meeting which comprised a formal presentation followed by a Q&amp;amp;A session.

Higher level of awareness of the project in lay and public sectir groups.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Annual lecture to Bipolar Fellowship</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6BCBBA08-C878-47F8-98D1-DCA2D23DECE5</gtr:id><gtr:impact>Annual lecture

Feedback and daalogue by email</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society of Edinburgh, Bruce Preller Lectureship</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0F3D7059-D1BF-4A01-9761-547CC872BAE2</gtr:id><gtr:impact>Circa 150 people attending the meeting which comprised a formal presentation followed by a Q&amp;amp;A session.

Follow up by attendees for further information</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gengage talk to school biology students</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8B67300A-C750-4214-86F7-9F8920585CD8</gtr:id><gtr:impact>120 pupils attended talk on genetics and ethics plus Q &amp;amp; A.

Strong feedback from teachers and pupils attending.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICCD Conversations</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>08895AD6-2FCC-4CAB-9580-B883711F2EDE</gtr:id><gtr:impact>Talk to ICCD supporters at networking meeting.

Invited back to talk at further meeting in New York (2009) and Glasgow (2009). Links to potential co-sponsors of mental health research.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>397000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>0BFB476F-4BC5-46E1-973E-8AEC34F472A0</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>141634</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust 4 year PhD studentship</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>083210</gtr:fundingRef><gtr:id>29EA0B72-3557-48B8-93CB-96992DDBA9BA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>326553</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>WT088179MA</gtr:fundingRef><gtr:id>C36FED91-BEA8-4A5C-94A5-07EE656BD4F0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A phospho-specific antibody raised to a PKA site that modulates protein-protein interactions.</gtr:description><gtr:id>74956685-96A1-4FCE-8830-F4A4ED307987</gtr:id><gtr:impact>This antibody detects a phosphorylation event at the endogenous level and was a key reagent in a publication this year.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>NDE1/NDEL1 pT131</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>a large number of expression constructs designed to examine DISC1 and interactors at the level of protein binding, phosphorylation, clinically relevant mutations, genetic variants, localisation etc</gtr:description><gtr:id>E8829FBD-FA75-47B5-AF04-F29BFCAD8E20</gtr:id><gtr:impact>We have been providing reagents to many laboratories (internationally) for a number of years. The materials are in current use by many laboratories for general protein biochemistry experiments.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>expression constructs</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>antibody specific to human DISC1</gtr:description><gtr:id>5563CA16-084E-4DD3-AB9C-378112533EBD</gtr:id><gtr:impact>We have provided this material to many laboratories over a number of years. It is still under investigation.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DISC1 antibodies</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>NeurocentRx Pharma Ltd</gtr:companyName><gtr:description>Neurocentrix is a virtual company built around the know how of several PI's in the Universuty of Edinburgh with expertise in neurological disorders - pain, mood and mental illness.; http://www.neurocentrx.com/</gtr:description><gtr:id>743C8974-0900-4DCD-B609-EDE7AB7F2549</gtr:id><gtr:impact>None as yet. Dependent upon raising investment capital.</gtr:impact><gtr:url>http://www.neurocentrx.com/</gtr:url><gtr:yearCompanyFormed>2008</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CAB4D58F-CF4A-41E5-B9D3-F4D614DBC2D6"><gtr:id>CAB4D58F-CF4A-41E5-B9D3-F4D614DBC2D6</gtr:id><gtr:title>PKA phosphorylation of NDE1 is DISC1/PDE4 dependent and modulates its interaction with LIS1 and NDEL1.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c34bee8146341bd5f9f6f63e7fb46028"><gtr:id>c34bee8146341bd5f9f6f63e7fb46028</gtr:id><gtr:otherNames>Bradshaw NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/320DC27B-1F9B-42C3-A07C-FD73E63529AF"><gtr:id>320DC27B-1F9B-42C3-A07C-FD73E63529AF</gtr:id><gtr:title>The DISC locus in psychiatric illness.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bae1e71a8cf1eb8867b827f65c5634a8"><gtr:id>bae1e71a8cf1eb8867b827f65c5634a8</gtr:id><gtr:otherNames>Chubb JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7E00D23-2E03-4643-9E18-E2A63B0041DF"><gtr:id>F7E00D23-2E03-4643-9E18-E2A63B0041DF</gtr:id><gtr:title>A t(1;11) translocation linked to schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that encode structurally altered, deleterious mitochondrial proteins.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3be486fcfaa39e8e78ceaa42dfb444ce"><gtr:id>3be486fcfaa39e8e78ceaa42dfb444ce</gtr:id><gtr:otherNames>Eykelenboom JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E52A8F00-B669-4471-B144-34DD2A151FFA"><gtr:id>E52A8F00-B669-4471-B144-34DD2A151FFA</gtr:id><gtr:title>Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf8f92044b07e66764171b2fa4bce1d8"><gtr:id>bf8f92044b07e66764171b2fa4bce1d8</gtr:id><gtr:otherNames>Ishizuka K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/56C72BC8-7B34-4088-9127-27CB6CB4AD0A"><gtr:id>56C72BC8-7B34-4088-9127-27CB6CB4AD0A</gtr:id><gtr:title>DISC1 variants 37W and 607F disrupt its nuclear targeting and regulatory role in ATF4-mediated transcription.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4897d2e3ff2ad9ea1f4eba4c7899d253"><gtr:id>4897d2e3ff2ad9ea1f4eba4c7899d253</gtr:id><gtr:otherNames>Malavasi EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05650EBB-DECB-4D42-AC34-25E0A2AE398F"><gtr:id>05650EBB-DECB-4D42-AC34-25E0A2AE398F</gtr:id><gtr:title>Co-ordinated action of DISC1, PDE4B and GSK3? in modulation of cAMP signalling.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eca967b1c7f2983b4a0874c64b9c0180"><gtr:id>eca967b1c7f2983b4a0874c64b9c0180</gtr:id><gtr:otherNames>Carlyle BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86B5B4C7-19AC-4CA1-865A-F9C419E0466C"><gtr:id>86B5B4C7-19AC-4CA1-865A-F9C419E0466C</gtr:id><gtr:title>Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d3286e7a6e404467d83d9f5c7828d1c"><gtr:id>0d3286e7a6e404467d83d9f5c7828d1c</gtr:id><gtr:otherNames>Millar JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B256199B-32A5-462C-A9F4-062EC2843495"><gtr:id>B256199B-32A5-462C-A9F4-062EC2843495</gtr:id><gtr:title>How DISC1 regulates postnatal brain development: girdin gets in on the AKT.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5d84c16547bc5ed8b588a2c31d167b60"><gtr:id>5d84c16547bc5ed8b588a2c31d167b60</gtr:id><gtr:otherNames>Porteous D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E0B01CC-8336-45C7-BCB8-2BA53D7F299E"><gtr:id>5E0B01CC-8336-45C7-BCB8-2BA53D7F299E</gtr:id><gtr:title>Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f1ca97b0dffda2fe87b00adf80d7272"><gtr:id>7f1ca97b0dffda2fe87b00adf80d7272</gtr:id><gtr:otherNames>Murdoch H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E18A668C-018D-4380-950C-2CC8344F5490"><gtr:id>E18A668C-018D-4380-950C-2CC8344F5490</gtr:id><gtr:title>DISC1 complexes with TRAK1 and Miro1 to modulate anterograde axonal mitochondrial trafficking.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e86f049fe4a668b930ad44620cae55d9"><gtr:id>e86f049fe4a668b930ad44620cae55d9</gtr:id><gtr:otherNames>Ogawa F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/906F4698-3FCF-410C-BCAC-07A3AB0CA500"><gtr:id>906F4698-3FCF-410C-BCAC-07A3AB0CA500</gtr:id><gtr:title>DISC1, PDE4B, and NDE1 at the centrosome and synapse.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c34bee8146341bd5f9f6f63e7fb46028"><gtr:id>c34bee8146341bd5f9f6f63e7fb46028</gtr:id><gtr:otherNames>Bradshaw NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8313D9BB-C7B3-4B38-96B4-6689D4E5B784"><gtr:id>8313D9BB-C7B3-4B38-96B4-6689D4E5B784</gtr:id><gtr:title>The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cd00b5751b792945e70ee187e8553402"><gtr:id>cd00b5751b792945e70ee187e8553402</gtr:id><gtr:otherNames>Hennah W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A719828-24C4-42A7-9087-9E824F98E126"><gtr:id>3A719828-24C4-42A7-9087-9E824F98E126</gtr:id><gtr:title>NDE1 and NDEL1: multimerisation, alternate splicing and DISC1 interaction.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c34bee8146341bd5f9f6f63e7fb46028"><gtr:id>c34bee8146341bd5f9f6f63e7fb46028</gtr:id><gtr:otherNames>Bradshaw NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/610E9237-BC98-4A9A-B9CE-C740C75E4A16"><gtr:id>610E9237-BC98-4A9A-B9CE-C740C75E4A16</gtr:id><gtr:title>Behavioral phenotypes of Disc1 missense mutations in mice.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/48899b30665038e751b8193ceb18b2f9"><gtr:id>48899b30665038e751b8193ceb18b2f9</gtr:id><gtr:otherNames>Clapcote SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D36D6901-272F-4687-8114-3B5FEDD03DC4"><gtr:id>D36D6901-272F-4687-8114-3B5FEDD03DC4</gtr:id><gtr:title>Understanding the role of DISC1 in psychiatric disease and during normal development.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2fd45ea54bf7960791e0165dd5c599fe"><gtr:id>2fd45ea54bf7960791e0165dd5c599fe</gtr:id><gtr:otherNames>Brandon NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F4DF98E1-50C2-4D29-954F-0B62DC3EB8FF"><gtr:id>F4DF98E1-50C2-4D29-954F-0B62DC3EB8FF</gtr:id><gtr:title>DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a539e3129d8da0b342323406bfd41a0"><gtr:id>4a539e3129d8da0b342323406bfd41a0</gtr:id><gtr:otherNames>Porteous DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA4289BC-5278-467E-BDDD-63EF89AD892A"><gtr:id>BA4289BC-5278-467E-BDDD-63EF89AD892A</gtr:id><gtr:title>Role of DISC1 in neural development and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f9cc04641da7488bf650b55731cb18e0"><gtr:id>f9cc04641da7488bf650b55731cb18e0</gtr:id><gtr:otherNames>Mackie S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600214</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>